featured
Perioperative Chemotherapy for Resectable Pancreatic Adenocarcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy of Perioperative Chemotherapy for Resectable Pancreatic Adenocarcinoma: A Phase 2 Randomized Clinical Trial
JAMA Oncol 2021 Jan 21;[EPub Ahead of Print], DPS Sohal, M Duong, SA Ahmad, NS Gandhi, MS Beg, A Wang-Gillam, JL Wade, EG Chiorean, KA Guthrie, AM Lowy, PA Philip, HS HochsterFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.